Hiv Prevention in Treatment Settings: U.S. and International Priorities

The summary for the Hiv Prevention in Treatment Settings: U.S. and International Priorities grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Hiv Prevention in Treatment Settings: U.S. and International Priorities: The estimated annual number of new HIV infections in the U.S. has remained steady at 40,000 for nearly ten years and HIV rates in many countries continue to rise alarmingly. Domestic and international HIV prevention programs have generally focused on HIV-negative persons, to help them avoid becoming infected. However, it has become increasingly apparent that to stem the tide of new infections, additional attention and resources should be focused on persons living with HIV, especially those in treatment. Behavioral interventions in HIV/AIDS treatment settings represent a critical domestic priority and are an emergent international priority. To develop enhanced HIV prevention strategies in treatment settings, there are important research gaps in basic, behavioral science, medical, and policy areas that need to be addressed. Studies are needed to (a) better understand the associations among HIV treatment response, treatment adherence, risk behavior, and other psychosocial factors that are likely to impact these variables (e.g., housing instability, substance abuse, depression, domestic violence); (b) develop innovative approaches to risk behavior change based in treatment settings, especially interventions that combine behavioral and medical/biological components; (c) examine optimal mechanisms for referral to services for prevention needs that are not feasible in medical settings; (d) increase medical care providers' linkage of persons to care who had previously not known their HIV serostatus; and (e) improve utilization of systems to facilitate partner notification. This Request for Applications (RFA) briefly reviews the complex interaction of basic, behavioral science, medical, and public policy issues that present challenges for the integration of HIV prevention into clinical care settings, and outlines important research priorities.
Federal Grant Title: Hiv Prevention in Treatment Settings: U.S. and International Priorities
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-MH-03-006
Type of Funding: Grant
CFDA Numbers: 93.24293.279
CFDA Descriptions: Mental Health Research Grants 93.279 Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 29, 2002
Posted Date: Jul 26, 2002
Creation Date: Dec 09, 2002
Archive Date: Dec 09, 2002
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.361 -- Nursing Research
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020